TIMP1 unfolds protective neurovascular effects in ischemic stroke [37], whereas both MMP12 and osteopontin receptor CD44 may critically contribute to ischemic brain damage [15, 114], suggesting that these proteins/genes may all be important therapeutic targets in ischemic stroke. This evidence concerns the gene TIMP1 and ischemic stroke.